Among the clinical sub-groups, the concordance rate and the sensitivity of EGFR plasma test were higher in patients with Ecog PS ≥ 2, pleural effusion, and tumor size > 5 cm compared to others but not with statistical significance (P > 0.05, Table 1). The gene discussed is EGFR; the disease is neoplasm.